Purple flowers filled the Elliman Conference Center on Nov. 11 as hundreds gathered for Chancellor Don Elliman’s 2026 State of the Campus address. Worn in recognition of Pancreatic Cancer Awareness Month and to honor a special guest in attendance, the flowers served as a powerful reminder of the lives behind the research, discoveries and breakthroughs happening every day at the University of Colorado Anschutz.
Chancellor Elliman highlighted major campus milestones from the past year, including a record $861.3 million in sponsored research awards, $236 million in philanthropic support and more than 5.1 million patient visits. He also celebrated groundbreaking discoveries, growing industry partnerships and the extraordinary people driving CU Anschutz forward.
Despite ongoing challenges facing academic medicine, our campus is not constrained by conventional boundaries. Chancellor Elliman said, “Our goal hasn’t changed. We are an excellent academic medical campus, and we intend to become one of the very, very best.
The question is how we get there. And the answer, in large part, lies in what makes CU Anschutz different.”
Take a deeper dive into the State of the Campus Companion Report to learn about what sets our campus apart.
Looking ahead, Chancellor Elliman emphasized the campus's unique ability to bring together leading-edge science, advanced data science technologies, innovative therapies and world-class clinical care to tackle some of medicine's toughest challenges. "This is our moment,” he said. “We have the opportunity to transform health and medicine."
The most powerful moment of the address brought that mission into deeply personal focus. Chancellor Elliman shared the story of Eliese Espinosa, a Colorado woman who faced a devastating pancreatic cancer diagnosis last year. Her scans showed extensive cancer lesions, and the prognosis was bleak.
When Eliese’s care team at CU Anschutz, led by Wells Messersmith, MD, offered her the opportunity to participate in a clinical trial, she didn't know whether the experimental treatment would help. But she said yes, hoping that even if it couldn't change her own outcome, it might help someone else facing the same diagnosis. What followed was extraordinary: Her tumors shrank by approximately 94%, giving her and her family something they hadn't dared to expect – more time, renewed hope and the chance to enjoy life's everyday moments together.
Watch the video highlighting Eliese’s journey.
With Eliese, her family and Dr. Messersmith in attendance, the sea of purple flowers took on even greater meaning. Her journey offered a powerful reminder of what's at stake behind every research breakthrough, clinical trial and collaboration. Eliese’s daughter, Rebekah Espinosa, said, “This research has given us not just more time, but the gift of being more present."
As Chancellor Elliman emphasized, the true strength of CU Anschutz lies in its people and their determination to keep searching for better answers – bringing new possibilities and new hope to patients and families when they need it most.
Check out State of the Campus highlights!